Quick Takeaways
- Robert B. Bazemore has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $420,401.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Robert B. Bazemore
- Location
- Lexington, MA
- Summary
- The estimated net worth of Robert B. Bazemore is at least $420,401 dollars as of 18 Dec 2025. Robert B. Bazemore is the Director of ARDELYX, INC. and owns shares of ARDELYX, INC. (ARDX) stock worth about $257.9K. Robert B. Bazemore is the Director of Akari Therapeutics Plc and owns shares of Akari Therapeutics Plc (AKTX) stock worth about $162.5K.
- Signature
- /s/ Abizer Gaslightwala, as Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Robert B. Bazemore and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: ARDELYX, INC. ($257,905).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Robert B. Bazemore
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ARDX | ARDELYX, INC. | Director | $257,905 | 18 Jun 2025 | ||
| AKTX | Akari Therapeutics Plc | Director | $162,496 | +$62,499 | +63% | 16 Dec 2025 |
| NUVB | Nuvation Bio Inc. | Director | 21 May 2025 |
Insider Transactions Reported by Robert B. Bazemore:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.